[Hepatitis C virus infection and thyroid diseases] (Q73085252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

[Hepatitis C virus infection and thyroid diseases] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

C Broussolle

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M P Steineur

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

F Bailly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Trépo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 September 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

Revue de Médecine Interne

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

766-773

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

Nonhepatic manifestations and combined diseases in HCV infection

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

[Extrahepatic manifestations of the hepatitis C virus]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

[Does hepatitis c virus-related autoimmune thyroiditis exist? Reflections on a controlled study of 58 consecutive subjects]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Prevalence of thyroid autoantibodies is not increased in blood donors with hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Failure to find an association between hepatitis C virus and thyroid autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

[Treatments of hepatitis C]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

The treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Side effects of alpha interferon in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

PRIMARY HYPOTHYROIDISM ASSOCIATED WITH INTERFERON THERAPY OF BREAST CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Induction of hyperthyroidism by interferon-alpha-2b

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Transient thyrotoxicosis and persistent hypothyroidism due to acute autoimmune thyroiditis after interleukin-2 and interferon-alpha therapy for metastatic carcinoma: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

[Autoimmune diseases and treatment with interferon-alpha: review of the literature apropos of a case of hyperthyroidism]

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Managing patients on interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Thyroid autoantibodies and thyroid dysfunction during treatment with interferon-alpha for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Interferon-associated thyroid dysfunction in anti-D-related chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Latent autoimmune thyroid disease in patients with chronic HCV hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Reversibility of thyroid dysfunction induced by recombinant alpha interferon in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Identification of a thyroid microsomal antigen by Western blot and immunoprecipitation

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Antithyroid peroxidase autoantibodies in thyroid diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Chronic autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Anti-thyroid peroxidase in non-neoplastic thyroid pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Anti-GOR and Anti-thyroid Autoantibodies in Patients with Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

The Pathogenesis of Autoimmune Thyroid Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

ev 22, a new endogenous avian leukosis virus locus found in chickens with spontaneous autoimmune thyroiditis

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Rheumatoid Arthritis-like Disease after Alpha-Interferon Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Alpha-interferon and immune hemolytic anemia

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Endocrine Evaluation in Patients Treated with Interferon-Alpha for Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-alpha therapy in patients with pre-existing thyroid disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

Suppression of HLA class II expression on thyrocytes by interferon-alpha 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0248-8663%2800%2988683-X

7 January 2021

10.1016/S0248-8663(00)88683-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10522298%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference